ProfileGDS4718 / 1560514_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 21% 20% 24% 18% 19% 23% 21% 20% 13% 19% 21% 17% 24% 25% 22% 18% 23% 26% 19% 39% 27% 23% 12% 12% 16% 26% 18% 22% 17% 31% 30% 23% 23% 20% 17% 21% 27% 21% 18% 17% 18% 22% 23% 21% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.2075621
GSM549102patient 115, normal, homogenized [OPG study]4.1473420
GSM549104patient 119, normal, homogenized [OPG study]4.2930224
GSM549108patient 138, normal, homogenized [OPG study]4.0977718
GSM549119patient 077, normal, homogenized [OPG study]4.1180719
GSM549133patient 032, cancer, homogenized [OPG study]4.2047723
GSM549139patient 042, cancer, homogenized [OPG study]4.1577721
GSM549099patient 107, normal, homogenized [OPG study]4.1567520
GSM549109patient 139, normal, homogenized [OPG study]3.9091713
GSM549110patient 046, normal, homogenized [OPG study]4.1003819
GSM549114patient 063, normal, homogenized [OPG study]4.1455521
GSM549122patient 082, normal, homogenized [OPG study]4.0382717
GSM549134patient 033, cancer, homogenized [OPG study]4.2921624
GSM549136patient 036, cancer, homogenized [OPG study]4.2889825
GSM549140patient 044, cancer, homogenized [OPG study]4.1984422
GSM549111patient 047, normal, homogenized [OPG study]4.0417218
GSM549113patient 057, normal, homogenized [OPG study]4.2091823
GSM549132patient 031, cancer, homogenized [OPG study]4.3491326
GSM549137patient 038, cancer, homogenized [OPG study]4.100219
GSM549142patient 047, cancer, homogenized [OPG study]5.0523139
GSM549100patient 110, normal, homogenized [OPG study]4.4264227
GSM549107patient 135, normal, homogenized [OPG study]4.2287823
GSM549115patient 068, normal, homogenized [OPG study]3.8334612
GSM549116patient 072, normal, homogenized [OPG study]3.8406312
GSM549120patient 078, normal, homogenized [OPG study]3.9919316
GSM549131patient 030, cancer, homogenized [OPG study]4.3141226
GSM549118patient 074, normal, homogenized [OPG study]4.0850918
GSM549129patient 027, cancer, homogenized [OPG study]4.2429722
GSM549123patient 088, normal, homogenized [OPG study]4.0497417
GSM549124patient 006, cancer, homogenized [OPG study]4.6051131
GSM549126patient 015, cancer, homogenized [OPG study]4.5188830
GSM549128patient 025, cancer, homogenized [OPG study]4.2202623
GSM549103patient 117, normal, homogenized [OPG study]4.289823
GSM549117patient 073, normal, homogenized [OPG study]4.1473420
GSM549138patient 041, cancer, homogenized [OPG study]4.0123117
GSM549141patient 045, cancer, homogenized [OPG study]4.1184121
GSM549130patient 028, cancer, homogenized [OPG study]4.4131227
GSM549101patient 111, normal, homogenized [OPG study]4.1900621
GSM549105patient 128, normal, homogenized [OPG study]4.0680918
GSM549106patient 134, normal, homogenized [OPG study]3.9942317
GSM549112patient 048, normal, homogenized [OPG study]4.0785318
GSM549125patient 011, cancer, homogenized [OPG study]4.241322
GSM549127patient 024, cancer, homogenized [OPG study]4.2225823
GSM549135patient 035, cancer, homogenized [OPG study]4.1227521